4LT1 Northern Oil & Gas Inc.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Northern Oil and Gas, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 17, 2016 – NOG

The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of Northern Oil and Gas, Inc. (NYSE MKT:NOG) between March 1, 2013 and August 15, 2016. You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Southern District of New York. To get more information go to:

http://www.zlk.com/pslra/northern-oil-and-gas-inc

or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that throughout the Class Period, defendants made materially false and misleading statements and/or failed to disclose that: (i) Northern Oil’s compliance policies with respect to SEC regulations and the Company’s Code of Business Conduct and Ethics were inadequate to detect and/or prevent misconduct by the Company’s officers; (ii) consequently, the Company’s CEO, Defendant Michael Reger (“Reger”), was able to engage in illegal stock manipulation during his tenure at Northern Oil; and (iii) Reger was consequently unfit to serve as CEO.

On August 16, 2016, Northern Oil terminated Reger following his August 11, 2016 disclosure that he may face federal sanctions in connection with the SEC’s investigation of 2012 trading patterns in the securities of Dakota Plains Holdings, Inc., a company in which Reger initially invested in 2008.

If you suffered a loss in Northern Oil you have until October 17, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

30 Broad Street - 24th Floor

New York, NY 10004

Tel: (212) 363-7500

Toll Free: (877) 363-5972

Fax: (212) 363-7171

www.zlk.com

EN
23/09/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Northern Oil & Gas Inc.

Moody's announces completion of a periodic review of ratings of Northe...

Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Northern Oil and Gas, Inc.. Global Credit Research- 11 Sep 2020. New York, September 11, 2020-- Moody's Investors Service has completed a periodic review of the ratings of Northern Oil and Gas, Inc. and other ratings that are associated with the same analytical unit.

Northern Oil and Gas, Inc: Update following rating outlook change to s...

NOG has moderate leverage, while its commodity hedges should support credit metrics and enable the company to generate free cash flow together with spending restraint in 2020.

Moody's changes Northern Oil and Gas' rating outlook to stable

Rating Action: Moody's changes Northern Oil and Gas' rating outlook to stable. Global Credit Research- 22 Jul 2020. New York, July 22, 2020-- Moody's Investors Service changed Northern Oil and Gas, Inc.' s rating outlook to stable from positive.

NORTHERN OIL & GAS INCO. sees a downgrade to Negative on account of le...

The independent financial analyst theScreener just lowered the general evaluation of NORTHERN OIL & GAS INCO. (US), active in the Exploration & Production industry. As regards its fundamental valuation, the title now shows 1 out of 4 stars while market behaviour can be considered risky. theScreener believes that the title remains under pressure due to the loss of a star(s) and downgrades its general evaluation to Negative. As of the analysis date June 26, 2020, the closing price was USD 0.84 and...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Tables: June 13, 2020

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

1A80 ACCELERATE DIAGNOSTICS INC.
TXMD THERAPEUTICSMD INC.
SANW S&W SEED CO
PNFP PINNACLE FINANCIAL PARTNERS INC.
ORI OLD REPUBLIC INTERNATIONAL CORPORATION
4LT1 NORTHERN OIL & GAS INC.
LQDT LIQUIDITY SERVICES
FOSL FOSSIL GROUP INC.
FGEN FIBROGEN INC.
EXTR EXTREME NETWORKS INC.
AVID AVID TECHNOLOGY INC.
ATO ATMOS ENERGY CORPORATION
ASB ASSOCIATED BANC-CORP
AMRS AMYRIS
AMG AFFILIATED MANAGERS GROUP INC.
ADS ALLIANCE DATA SYSTEMS CORPORATION
AMWD AMERICAN WOODMARK CORPORATION
CERC CERECOR INC
CNA CNA FINANCIAL CORPORATION
CCV COUNTERPATH
FLXS FLEXSTEEL INDUSTRIES INC.
LSXMA LIBERTY MEDIA CORP. SERIES A LIBERTY SIRIUSXM
RILY B RILEY SECURITIES INC
CNBKA CENTURY BANCORP INC. CL A
CWH CAMPING WORLD HOLDINGS INC. CLASS A
PHD PIONEER FLOATING RATE
CDEV CENTENNIAL RESOURCE DEVELOPMENT INC. CLASS A
MRUS MERUS B V
ATH ATHENE HOLDING LTD. CLASS A
CLRB CELLECTAR BIOSCIENCES
KALA KALA PHARMACEUTICALS INC.
ALRN AILERON THERAPEUTICS
RCUS ARCUS BIOSCIENCES
MNLO MENLO THERAPEUTICS INC
BHC BAUSCH HEALTH COMPANIES INC.
KZR KEZAR LIFE SCIENCES
ETTX ENTASIS THERAPEUTICS HOLDINGS
REZI RESIDEO TECHNOLOGIES
KLDO INC.
APRN KALEIDO BIOSCIENCES
BW BLUE APRON HOLDINGS
WTRE BABCOCK & WILCOX ENTERPRISES
ARCT WATFORD HOLDINGS
CHNG ARCTURUS THERAPEUTICS HOLDINGS INC
LSXMK CHANGE HEALTHCARE INC.
EVF LIBERTY MEDIA CORP. SERIES C LIBERTY SIRIUSXM
CLDX EATON VANCE SENIOR INCOME TRUST
APDN CELLDEX THERAPEUTICS INC.
SONM APPLIED DNA SCIENCES INC.
BCSF SONIM TECHNOLOGIES
CRDB BAIN CAPITAL SPECIALTY FINANCE
SIC CRAWFORD & COMPANY
MCACU SELECT INTERIOR CONCEPTS
MOUNTAIN CREST ACQUISITION CORP.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch